Skip to content

Author

Jv-Liang Dai

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jul 2026

Advances in engineering microalgae for heterologous terpenoid synthesis: A review.

Terpenoids are a class of natural products widely distributed in living organisms, with isoprene as their fundamental structural unit. However, traditional plant extraction and chemical synthesis methods are often limited by low product purity, difficult separation, and complex synthetic steps, making it challenging to meet the demands of large-scale production. Conventional hosts such as Escherichia coli and Saccharomyces cerevisiae are utilized for terpenoid synthesis due to their advantages of short growth cycles and controllable cultivation conditions. Nevertheless, the complexity of terpenoid biosynthetic pathways poses significant challenges for these hosts in producing structurally complex terpenoids. In contrast, microalgae as photosynthetic microorganisms, possess well-developed endogenous terpenoid metabolic pathways, abundant precursor pools, and subcellular structures and regulatory mechanisms similar to those of plants, demonstrating significant advantages in the heterologous production of complex terpenoids. This review systematically summarizes recent advances in the production of heterologously synthesized terpenoids in eukaryotic microalgae, ranging from monoterpenes to triterpenes, and provides an in-depth analysis of key engineering strategies, including MEP/MVA pathway regulation, gene expression optimization, subcellular compartmentalization, and cultivation process intensification. In addition, the application potential of advanced tools such as CRISPR/Cas, microalgae-microorganism co-culture, and artificial intelligence is introduced. Finally, the major bottlenecks faced by microalgae as a sustainable green cell factory for terpenoid production are briefly analyzed, and future research directions are proposed.

Yue-Li Yuan, Jv-Liang Dai, Ling Xiao et al. · 0 citations
Review Jul 2026

De novo synthesis of large-scale metabolic pathways for natural products and their optimization strategies.

Natural products constitute a vital source for drug discovery, yet extraction from producers is inefficient and chemical synthesis involves complex, low yield routes, limiting sustainable supply. Reconstructing large scale metabolic pathways (≥10 enzymatic steps) in microbial cell factories using synthetic biology offers a promising solution for efficient and sustainable production of high value natural products. This review systematically analyzes core strategies and cutting edge technologies for reconstructing such pathways, including advanced cloning methods, modular pathway design, self assembly approaches (protein/DNA scaffolds and metabolic channeling), division of labor optimization in co culture systems, and dynamic regulation mechanisms (promoter engineering, riboswitches, biosensor based feedback control). We further explore the emerging roles of systems biology modeling and machine learning in retrosynthetic pathway design, rational enzyme engineering, and precise metabolic flux regulation. By integrating intelligent algorithms with multidisciplinary tools, these approaches hold promise for overcoming bottlenecks in the biomanufacturing of complex natural products, thereby accelerating drug development and enabling green, sustainable production. This review highlights the importance of combining rational design, dynamic control, and modular co culture strategies to address challenges such as metabolic burden, pathway imbalance, and host toxicity, ultimately paving the way for scalable and cost effective biosynthesis of natural product pharmaceuticals.

Jia-Yi Jiang, Jv-Liang Dai, Hao-Hong Chen et al. · 0 citations